The paradox of the first cycle of chemotherapy—transient improvement of contractility and diastolic function after the first cycle of anthracycline-based chemotherapy: a prospective clinical trial

AIMS: Breast cancer is the most common cancer among women, and anthracyclines are the most commonly administered drugs for these patients. Cardiotoxicity is one of the complications, which limits the success of this therapy. Very few studies have evaluated anthracycline toxicities within the first f...

Descripción completa

Detalles Bibliográficos
Autores principales: Stachowiak, Paweł, Wojtarowicz, Andrzej, Milchert-Leszczyńska, Marta, Safranow, Krzysztof, Falco, Michał, Kaliszczak, Robert, Kornacewicz-Jach, Zdzisława
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707113/
https://www.ncbi.nlm.nih.gov/pubmed/29221219
http://dx.doi.org/10.18632/oncotarget.21279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707113/
https://www.ncbi.nlm.nih.gov/pubmed/29221219
http://dx.doi.org/10.18632/oncotarget.21279

Ejemplares similares